Literature DB >> 6310415

Evidence for opiate receptors on pituicytes.

S L Lightman, M Ninkovic, S P Hunt, L L Iversen.   

Abstract

A hypothalamo-neurohypophyseal enkephalinergic pathway has been described and the pars nervosa of the rat pituitary contains enkephalin-like material which may coexist in vasopressin and oxytocin terminals. At the level of the pars nervosa itself, stereospecific opiate receptors with properties very similar to those of brain receptors have been described, and opiates have been shown to inhibit the release of both vasopressin and oxytocin. The location of the opiate receptors involved has been presumed to be pre-terminal on the neurosecretory fibres. Using an autoradiographic technique to visualize opiate receptors, however, we now report that destruction of the neurosecretory fibres following pituitary stalk section does not result in a significant change in the neural lobe opiate receptor population. This suggests that the opiate receptors within the neural lobe may be present on pituicytes rather than on neurosecretory fibres.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310415     DOI: 10.1038/305235a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  13 in total

1.  Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin.

Authors:  A L Svingos; A Moriwaki; J B Wang; G R Uhl; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

Review 2.  Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications.

Authors:  C A Bondy; M H Whitnall; L S Brady; H Gainer
Journal:  Cell Mol Neurobiol       Date:  1989-12       Impact factor: 5.046

3.  kappa-Opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover.

Authors:  J Barg; M M Belcheva; J Rowiński; C J Coscia
Journal:  J Neurochem       Date:  1993-04       Impact factor: 5.372

4.  Localization of vasopressin mRNA and immunoreactivity in pituicytes of pituitary stalk-transected rats after osmotic stimulation.

Authors:  L P Pu; F W Van Leeuwen; H L Tracer; M A Sonnemans; Y P Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.

Authors:  G Dayanithi; E L Stuenkel; J J Nordmann
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

6.  Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones?

Authors:  J J Nordmann; G Dayanithi; M Cazalis
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

7.  Delta and kappa opiate receptors in primary astroglial cultures from rat cerebral cortex.

Authors:  P S Eriksson; E Hansson; L Rönnbäck
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

8.  Differential effects of various opioid peptides on vasopressin and oxytocin release from the rat pituitary in vitro.

Authors:  D Maysinger; I Vermes; F Tilders; B R Seizinger; C Gramsch; V Höllt; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

9.  Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat.

Authors:  S L Lightman; W S Young
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

10.  Opiate binding differentially associated with oxytocin and vasopressin nerve endings from porcine neurohypophyses.

Authors:  N Falke; R Martin
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.